Literature DB >> 27853813

Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scans.

Philipp Lohmann1, Gabriele Stoffels2, Garry Ceccon3, Marion Rapp4, Michael Sabel4, Christian P Filss2,5, Marcel A Kamp4, Carina Stegmayr2, Bernd Neumaier2, Nadim J Shah2,6,7, Karl-Josef Langen2,5,7, Norbert Galldiks2,3,8.   

Abstract

OBJECTIVES: We investigated the potential of textural feature analysis of O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET to differentiate radiation injury from brain metastasis recurrence.
METHODS: Forty-seven patients with contrast-enhancing brain lesions (n = 54) on MRI after radiotherapy of brain metastases underwent dynamic 18F-FET PET. Tumour-to-brain ratios (TBRs) of 18F-FET uptake and 62 textural parameters were determined on summed images 20-40 min post-injection. Tracer uptake kinetics, i.e., time-to-peak (TTP) and patterns of time-activity curves (TAC) were evaluated on dynamic PET data from 0-50 min post-injection. Diagnostic accuracy of investigated parameters and combinations thereof to discriminate between brain metastasis recurrence and radiation injury was compared.
RESULTS: Diagnostic accuracy increased from 81 % for TBRmean alone to 85 % when combined with the textural parameter Coarseness or Short-zone emphasis. The accuracy of TBRmax alone was 83 % and increased to 85 % after combination with the textural parameters Coarseness, Short-zone emphasis, or Correlation. Analysis of TACs resulted in an accuracy of 70 % for kinetic pattern alone and increased to 83 % when combined with TBRmax.
CONCLUSIONS: Textural feature analysis in combination with TBRs may have the potential to increase diagnostic accuracy for discrimination between brain metastasis recurrence and radiation injury, without the need for dynamic 18F-FET PET scans. KEY POINTS: • Textural feature analysis provides quantitative information about tumour heterogeneity • Textural features help improve discrimination between brain metastasis recurrence and radiation injury • Textural features might be helpful to further understand tumour heterogeneity • Analysis does not require a more time consuming dynamic PET acquisition.

Entities:  

Keywords:  Brain metastasis; FET PET; Radiation injury; Radiomics; Textural analysis

Mesh:

Substances:

Year:  2016        PMID: 27853813     DOI: 10.1007/s00330-016-4638-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  53 in total

1.  Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.

Authors:  Philipp Lohmann; Hans Herzog; Elena Rota Kops; Gabriele Stoffels; Natalie Judov; Christian Filss; Norbert Galldiks; Lutz Tellmann; Carolin Weiss; Michael Sabel; Heinz Hubert Coenen; Nadim Jon Shah; Karl-Josef Langen
Journal:  Eur Radiol       Date:  2015-03-27       Impact factor: 5.315

2.  FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Authors:  Gabriele Pöpperl; Friedrich W Kreth; Jan H Mehrkens; Jochen Herms; Klaus Seelos; Walter Koch; Franz J Gildehaus; Hans A Kretzschmar; Jörg C Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

3.  Evolution of radiation-induced brain injury: MR imaging-based study.

Authors:  Yi-Xiang J Wang; Ann D King; Hua Zhou; Sing-Fei Leung; Jill Abrigo; Yu-Leung Chan; Chen-Wen Hu; David K W Yeung; Anil T Ahuja
Journal:  Radiology       Date:  2009-12-17       Impact factor: 11.105

Review 4.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

5.  Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?

Authors:  Gary J R Cook; Connie Yip; Muhammad Siddique; Vicky Goh; Sugama Chicklore; Arunabha Roy; Paul Marsden; Shahreen Ahmad; David Landau
Journal:  J Nucl Med       Date:  2012-11-30       Impact factor: 10.057

Review 6.  Stereotactic radiosurgery in the treatment of brain metastases: the current evidence.

Authors:  Bodo Lippitz; Christer Lindquist; Ian Paddick; David Peterson; Kevin O'Neill; Ronald Beaney
Journal:  Cancer Treat Rev       Date:  2013-06-27       Impact factor: 12.111

7.  Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.

Authors:  Nathalie L Jansen; Bogdana Suchorska; Vera Wenter; Sabina Eigenbrod; Christine Schmid-Tannwald; Andreas Zwergal; Maximilian Niyazi; Mark Drexler; Peter Bartenstein; Oliver Schnell; Jörg-Christian Tonn; Niklas Thon; Friedrich-Wilhelm Kreth; Christian la Fougère
Journal:  J Nucl Med       Date:  2013-12-30       Impact factor: 10.057

8.  Development and evaluation of an open-source software package "CGITA" for quantifying tumor heterogeneity with molecular images.

Authors:  Yu-Hua Dean Fang; Chien-Yu Lin; Meng-Jung Shih; Hung-Ming Wang; Tsung-Ying Ho; Chun-Ta Liao; Tzu-Chen Yen
Journal:  Biomed Res Int       Date:  2014-03-17       Impact factor: 3.411

Review 9.  Tumour heterogeneity and cancer cell plasticity.

Authors:  Corbin E Meacham; Sean J Morrison
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

10.  Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials.

Authors:  Clément Bailly; Caroline Bodet-Milin; Solène Couespel; Hatem Necib; Françoise Kraeber-Bodéré; Catherine Ansquer; Thomas Carlier
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

View more
  30 in total

Review 1.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

2.  Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement.

Authors:  Ji Eun Park; Donghyun Kim; Ho Sung Kim; Seo Young Park; Jung Youn Kim; Se Jin Cho; Jae Ho Shin; Jeong Hoon Kim
Journal:  Eur Radiol       Date:  2019-07-26       Impact factor: 5.315

Review 3.  "Radio-oncomics" : The potential of radiomics in radiation oncology.

Authors:  Jan Caspar Peeken; Fridtjof Nüsslin; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2017-07-07       Impact factor: 3.621

Review 4.  Radiomics in Oncological PET/CT: Clinical Applications.

Authors:  Jeong Won Lee; Sang Mi Lee
Journal:  Nucl Med Mol Imaging       Date:  2017-10-20

5.  Added Value of Contrast Medium in Whole-Body Hybrid Positron Emission Tomography/Magnetic Resonance Imaging: Comparison between Contrast-Enhanced and Non-Contrast-Enhanced Protocols.

Authors:  Filiz Celebi; Emetullah Cindil; Dauren Sarsenov; Bulent Unalan; Cem Balcı
Journal:  Med Princ Pract       Date:  2019-06-17       Impact factor: 1.927

6.  PET imaging in patients with brain metastasis-report of the RANO/PET group.

Authors:  Norbert Galldiks; Karl-Josef Langen; Nathalie L Albert; Marc Chamberlain; Riccardo Soffietti; Michelle M Kim; Ian Law; Emilie Le Rhun; Susan Chang; Julian Schwarting; Stephanie E Combs; Matthias Preusser; Peter Forsyth; Whitney Pope; Michael Weller; Jörg C Tonn
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

7.  Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.

Authors:  Garry Ceccon; Lazaros Lazaridis; Gabriele Stoffels; Marion Rapp; Manuel Weber; Tobias Blau; Phillip Lohmann; Sied Kebir; Ken Herrmann; Gereon R Fink; Karl-Josef Langen; Martin Glas; Norbert Galldiks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-21       Impact factor: 9.236

8.  Predictors for a further local in-brain progression after re-craniotomy of locally recurrent cerebral metastases.

Authors:  Marcel A Kamp; Igor Fischer; Maxine Dibué-Adjei; Christopher Munoz-Bendix; Jan-Frederick Cornelius; Hans-Jakob Steiger; Philipp J Slotty; Bernd Turowski; Marion Rapp; Michael Sabel
Journal:  Neurosurg Rev       Date:  2017-12-20       Impact factor: 3.042

9.  Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression.

Authors:  Norbert Galldiks; Martin Kocher; Garry Ceccon; Jan-Michael Werner; Anna Brunn; Martina Deckert; Whitney B Pope; Riccardo Soffietti; Emilie Le Rhun; Michael Weller; Jörg C Tonn; Gereon R Fink; Karl-Josef Langen
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

Review 10.  The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective.

Authors:  Robert H Press; Hui-Kuo G Shu; Hyunsuk Shim; James M Mountz; Brenda F Kurland; Richard L Wahl; Ella F Jones; Nola M Hylton; Elizabeth R Gerstner; Robert J Nordstrom; Lori Henderson; Karen A Kurdziel; Bhadrasain Vikram; Michael A Jacobs; Matthias Holdhoff; Edward Taylor; David A Jaffray; Lawrence H Schwartz; David A Mankoff; Paul E Kinahan; Hannah M Linden; Philippe Lambin; Thomas J Dilling; Daniel L Rubin; Lubomir Hadjiiski; John M Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-30       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.